Fred Alger Management LLC Sells 9,677 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Fred Alger Management LLC lessened its position in U.S. Physical Therapy, Inc. (NYSE:USPH) by 5.2% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 176,620 shares of the company’s stock after selling 9,677 shares during the period. Fred Alger Management LLC owned 1.17% of U.S. Physical Therapy worth $16,323,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of USPH. Conestoga Capital Advisors LLC increased its stake in shares of U.S. Physical Therapy by 1.0% during the first quarter. Conestoga Capital Advisors LLC now owns 15,075 shares of the company’s stock valued at $1,702,000 after buying an additional 145 shares during the period. Texas Permanent School Fund Corp boosted its holdings in U.S. Physical Therapy by 1.3% in the first quarter. Texas Permanent School Fund Corp now owns 13,116 shares of the company’s stock valued at $1,480,000 after acquiring an additional 170 shares in the last quarter. First Horizon Advisors Inc. boosted its holdings in U.S. Physical Therapy by 18.6% in the second quarter. First Horizon Advisors Inc. now owns 1,188 shares of the company’s stock valued at $110,000 after acquiring an additional 186 shares in the last quarter. Louisiana State Employees Retirement System increased its position in U.S. Physical Therapy by 2.7% during the 2nd quarter. Louisiana State Employees Retirement System now owns 7,600 shares of the company’s stock valued at $702,000 after purchasing an additional 200 shares during the period. Finally, ProShare Advisors LLC raised its holdings in U.S. Physical Therapy by 7.4% in the 1st quarter. ProShare Advisors LLC now owns 3,002 shares of the company’s stock worth $339,000 after purchasing an additional 206 shares in the last quarter.

U.S. Physical Therapy Stock Performance

Shares of USPH stock opened at $84.32 on Thursday. The company’s fifty day moving average price is $87.80 and its 200-day moving average price is $96.58. The stock has a market cap of $1.27 billion, a PE ratio of 68.55, a price-to-earnings-growth ratio of 4.07 and a beta of 1.39. The company has a current ratio of 1.88, a quick ratio of 1.88 and a debt-to-equity ratio of 0.28. U.S. Physical Therapy, Inc. has a 12 month low of $78.08 and a 12 month high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Tuesday, August 13th. The company reported $0.73 earnings per share for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). U.S. Physical Therapy had a return on equity of 8.18% and a net margin of 4.06%. The business had revenue of $167.19 million during the quarter, compared to analysts’ expectations of $163.34 million. During the same quarter last year, the company posted $0.76 EPS. U.S. Physical Therapy’s revenue for the quarter was up 10.4% compared to the same quarter last year. On average, equities analysts expect that U.S. Physical Therapy, Inc. will post 2.51 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Friday, August 23rd were paid a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a yield of 2.09%. The ex-dividend date was Friday, August 23rd. U.S. Physical Therapy’s payout ratio is 143.09%.

Insiders Place Their Bets

In related news, Director Kathleen A. Gilmartin purchased 2,000 shares of U.S. Physical Therapy stock in a transaction dated Tuesday, September 3rd. The stock was purchased at an average cost of $86.09 per share, for a total transaction of $172,180.00. Following the completion of the acquisition, the director now directly owns 18,904 shares of the company’s stock, valued at $1,627,445.36. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. In related news, COO Graham D. Reeve sold 1,724 shares of the company’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total value of $142,230.00. Following the transaction, the chief operating officer now directly owns 7,038 shares of the company’s stock, valued at approximately $580,635. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Kathleen A. Gilmartin bought 2,000 shares of U.S. Physical Therapy stock in a transaction on Tuesday, September 3rd. The stock was acquired at an average cost of $86.09 per share, with a total value of $172,180.00. Following the acquisition, the director now owns 18,904 shares in the company, valued at approximately $1,627,445.36. The disclosure for this purchase can be found here. Corporate insiders own 1.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. Barrington Research reaffirmed an “outperform” rating and set a $108.00 target price on shares of U.S. Physical Therapy in a research note on Friday, September 20th. StockNews.com upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.